Your browser doesn't support javascript.
loading
Specific Multiomic Profiling in Aortic Stenosis in Bicuspid Aortic Valve Disease.
Antequera-González, Borja; Martínez-Micaelo, Neus; Sureda-Barbosa, Carlos; Galian-Gay, Laura; Siliato-Robles, M Sol; Ligero, Carmen; Evangelista, Artur; Alegret, Josep M.
Afiliación
  • Antequera-González B; Group of Cardiovascular Research, Pere Virgili Health Research Institute (IISPV), Universitat Rovira i Virgili, 43204 Reus, Spain.
  • Martínez-Micaelo N; Group of Cardiovascular Research, Pere Virgili Health Research Institute (IISPV), Universitat Rovira i Virgili, 43204 Reus, Spain.
  • Sureda-Barbosa C; Cardiac Surgery Department, Hospital Vall d'Hebron (CIBERCV), Universitat Autonoma de Barcelona, 08035 Barcelona, Spain.
  • Galian-Gay L; Cardiology Department, Hospital Vall d'Hebron (CIBERCV), Universitat Autonoma de Barcelona, 08035 Barcelona, Spain.
  • Siliato-Robles MS; Cardiac Surgery Department, Hospital Vall d'Hebron (CIBERCV), Universitat Autonoma de Barcelona, 08035 Barcelona, Spain.
  • Ligero C; Group of Cardiovascular Research, Pere Virgili Health Research Institute (IISPV), Universitat Rovira i Virgili, 43204 Reus, Spain.
  • Evangelista A; Cardiology Department, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, 43204 Reus, Spain.
  • Alegret JM; Cardiology Department, Hospital Vall d'Hebron (CIBERCV), Universitat Autonoma de Barcelona, 08035 Barcelona, Spain.
Biomedicines ; 12(2)2024 Feb 06.
Article en En | MEDLINE | ID: mdl-38397982
ABSTRACT
INTRODUCTION AND

PURPOSE:

Bicuspid aortic valve (BAV) disease is associated with faster aortic valve degeneration and a high incidence of aortic stenosis (AS). In this study, we aimed to identify differences in the pathophysiology of AS between BAV and tricuspid aortic valve (TAV) patients in a multiomics study integrating metabolomics and transcriptomics as well as clinical data.

METHODS:

Eighteen patients underwent aortic valve replacement due to severe aortic stenosis 8 of them had a TAV, while 10 of them had a BAV. RNA sequencing (RNA-seq) and proton nuclear magnetic resonance spectroscopy (1H-NMR) were performed on these tissue samples to obtain the RNA profile and lipid and low-molecular-weight metabolites. These results combined with clinical data were posteriorly compared, and a multiomic profile specific to AS in BAV disease was obtained.

RESULTS:

H-NMR results showed that BAV patients with AS had different metabolic profiles than TAV patients. RNA-seq also showed differential RNA expression between the groups. Functional analysis helped connect this RNA pattern to mitochondrial dysfunction. Integration of RNA-seq, 1H-NMR and clinical data helped create a multiomic profile that suggested that mitochondrial dysfunction and oxidative stress are key players in the pathophysiology of AS in BAV disease.

CONCLUSIONS:

The pathophysiology of AS in BAV disease differs from patients with a TAV and has a specific RNA and metabolic profile. This profile was associated with mitochondrial dysfunction and increased oxidative stress.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2024 Tipo del documento: Article